INM

Conviction 49HealthcareScan · Mon, Aug 10, 2026

Inverted hammer

INM$1.42-3.40%

ResistanceSupportVol 14Insider buy

Vol MA14 3.96M

May 11May 28Jun 16Jul 6Jul 23Aug 10

InMed Pharmaceuticals Inc.Pharmaceutical Preparationswww.inmedpharma.com ↗

Price1.42

Change-3.40%

Gap-4.76%

Rel volume0.03×

Avg volume2.78M

Avg $ vol4.62M

SMA 201.56

SMA 501.56

SMA 2001.22

Price vs 50-8.80%

Price vs 200+16.79%

MA stackmixed

50/200 cross—

Supertrenddown · 1.80

RSI (14)42

MACD hist-0.03

MACD crossbear · 8d

Stoch %K / %D2 / 4

ADX (14)38

+DI / −DI24 / 17

RSI divergence—

MACD divergence—

ATR %+8.70%

ADR %9.06%

52w high2.46

52w low0.6150

From 52w high-42.28%

Above 52w low+130.89%

New 52w highNo

SqueezeOff

Bollinger width28.67%

%B0.19

Donchian pos2.15%

Donchian high2.33

Donchian low1.40

AVWAP (52w high)1.60

vs AVWAP high-11.06%

AVWAP (52w low)1.65

vs AVWAP low-14.13%

OBV trendUp

Chaikin MF (20)-0.56

Today vs 20d0.03×

Avg vol (14d)3.96M

Avg vol (20d)2.78M

Avg $ vol (20d)4.62M

Market cap4.71M

RS 3m (vs SPY)+105.39%

RS 6m (vs SPY)+35.64%

RS line new highNo

Trend template3/8

Technical rank60.5

1 week-2.74%

1 month-13.41%

3 months+118.46%

6 months+51.02%

1 year-36.61%

YTD+26.79%

P/E-0.58

P/B0.68

P/S3.45

P/FCF-0.61

EPS-8.36

Div yield—

ROE-118.43%

ROA-89.36%

Debt/Eq0.00

Current3.12

EV/EBITDA0.05

Gross margin124.96%

Net margin-597.63%

Rev growth-28.27%

EPS growth-6.34%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-423.65K

Revenue309.58K

Net income-2.97M

Gross profit184.19K

Free cash flow-7.78M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out3.31M

Employees13

ListedTue, Nov 10, 2020

Free float2.6M

Float %89.2%

Short interest119.22K

Days to cover2.6d

Short volume29.1%

Squeeze score22 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank60.5 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmInverted hammer

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INM

All disclosures →

No recent disclosed trades by Congress in INM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in INM · 10 buys

Insider	Side	Shares	Value	Traded	Filed
ADAR1 Capital Management, LLC 10% owner · Common Shares · 2026-07-15	Buy	1K	$2K	2026-07-15	2026-07-17
Vivo Opportunity, LLC 10% owner · Common Shares · 2026-07-16	Buy	19	$29	2026-07-16	2026-07-16
Vivo Opportunity, LLC 10% owner · Common Shares · 2026-07-16	Buy	2	$3	2026-07-16	2026-07-16
Vivo Opportunity, LLC 10% owner · Common Shares · 2026-07-15	Buy	13.76K	$21K	2026-07-15	2026-07-16
Vivo Opportunity, LLC 10% owner · Common Shares · 2026-07-15	Buy	1.39K	$2K	2026-07-15	2026-07-16
Vivo Opportunity, LLC 10% owner · Common Shares · 2026-07-14	Buy	4.88K	$8K	2026-07-14	2026-07-16
Vivo Opportunity, LLC 10% owner · Common Shares · 2026-07-14	Buy	493	$764	2026-07-14	2026-07-16
Vivo Opportunity Fund Holdings, L.P. 10% owner · Common Shares · 2026-06-08	Buy	2.98K	$5K	2026-06-08	2026-06-10
Vivo Opportunity Cayman, LLC 10% owner · Common Shares · 2026-06-08	Buy	2.98K	$5K	2026-06-08	2026-06-10
Vivo Opportunity, LLC 10% owner · Common Shares · 2026-06-08	Buy	29.52K	$45K	2026-06-08	2026-06-10

SEC filings

EDGAR filings in INM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.